{"altmetric_id":3392105,"counts":{"readers":{"mendeley":9,"citeulike":0,"connotea":0},"total":{"posts_count":1},"wikipedia":{"unique_users_count":1,"unique_users":["en:4716245"],"posts_count":1}},"citation":{"abstract":"To assess the pharmacologic effects and abuse liability of bretazenil, a partial benzodiazepine agonist, and compare them to the short-term effects of diazepam and alprazolam over a range of doses.","abstract_source":"pubmed","altmetric_jid":"4f6fa5e63cf058f61000580f","authors":["U Busto","H L Kaplan","L Zawertailo","E M Sellers"],"first_seen_on":"2015-02-06T11:52:56+00:00","issns":["0009-9236"],"issue":"4","journal":"Clinical Pharmacology & Therapeutics","last_mentioned_on":1265908256,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8162672"],"pmid":"8162672","pubdate":"1994-04-01T00:00:00+00:00","publisher_subjects":[{"name":"Pharmacology And Pharmaceutical Sciences","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Pharmacology, Toxicology and Pharmaceutics"],"subjects":["pharmacology","drugtherapy"],"title":"Pharmacologic effects and abuse liability of bretazenil, diazepam, and alprazolam in humans.","type":"article","volume":"55","mendeley_url":"http:\/\/www.mendeley.com\/research\/pharmacologic-effects-abuse-liability-bretazenil-diazepam-alprazolam-humans"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":3628216,"mean":4.9435109727551,"rank":817227,"this_scored_higher_than_pct":63,"this_scored_higher_than":2287850,"rank_type":"exact","sample_size":3628216,"percentile":63},"similar_age_3m":{"total_number_of_other_articles":93789,"mean":8.0665511579308,"rank":24268,"this_scored_higher_than_pct":72,"this_scored_higher_than":68446,"rank_type":"exact","sample_size":93789,"percentile":72},"this_journal":{"total_number_of_other_articles":977,"mean":3.2327540983607,"rank":214,"this_scored_higher_than_pct":56,"this_scored_higher_than":555,"rank_type":"exact","sample_size":977,"percentile":56},"similar_age_this_journal_3m":{"total_number_of_other_articles":29,"mean":1.5089285714286,"rank":4,"this_scored_higher_than_pct":86,"this_scored_higher_than":25,"rank_type":"exact","sample_size":29,"percentile":86}}},"demographics":{"users":{"mendeley":{"by_status":{"Professor > Associate Professor":2,"Researcher":2,"Student  > Ph. D. Student":2,"Student  > Master":1,"Professor":1,"Student  > Bachelor":1},"by_discipline":{"Medicine and Dentistry":3,"Neuroscience":1,"Psychology":1,"Agricultural and Biological Sciences":2,"Pharmacology, Toxicology and Pharmaceutical Science":2}}}},"posts":{"wikipedia":[{"title":"Bretazenil","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=343374033#altmetric_citation_5","license":"public","citation_ids":[3392104,3392105],"posted_on":"2010-02-11T17:10:56+00:00","summary":"Bretazenil (Ro16-6028) is an imidazopyrrolobenzodiazepine anxiolytic drug which is derived from the benzodiazepine family, and was invented in 1988.","page_url":"http:\/\/en.wikipedia.org\/?curid=4716245","wiki_lang":"en","author":{"name":"Literaturegeek","url":"http:\/\/en.wikipedia.org\/wiki\/User:Literaturegeek"}}]}}